thalidomide has been researched along with Cytomegalovirus in 2 studies
Thalidomide: A piperidinyl isoindole originally introduced as a non-barbiturate hypnotic, but withdrawn from the market due to teratogenic effects. It has been reintroduced and used for a number of immunological and inflammatory disorders. Thalidomide displays immunosuppressive and anti-angiogenic activity. It inhibits release of TUMOR NECROSIS FACTOR-ALPHA from monocytes, and modulates other cytokine action.
thalidomide : A racemate comprising equimolar amounts of R- and S-thalidomide.
2-(2,6-dioxopiperidin-3-yl)-1H-isoindole-1,3(2H)-dione : A dicarboximide that is isoindole-1,3(2H)-dione in which the hydrogen attached to the nitrogen is substituted by a 2,6-dioxopiperidin-3-yl group.
Cytomegalovirus: A genus of the family HERPESVIRIDAE, subfamily BETAHERPESVIRINAE, infecting the salivary glands, liver, spleen, lungs, eyes, and other organs, in which they produce characteristically enlarged cells with intranuclear inclusions. Infection with Cytomegalovirus is also seen as an opportunistic infection in AIDS.
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 1 (50.00) | 2.80 |
Authors | Studies |
---|---|
Groves, IJ | 1 |
Jackson, SE | 1 |
Poole, EL | 1 |
Nachshon, A | 1 |
Rozman, B | 1 |
Schwartz, M | 1 |
Prinjha, RK | 1 |
Tough, DF | 1 |
Sinclair, JH | 1 |
Wills, MR | 1 |
Kim, JH | 1 |
Goulston, C | 1 |
Sanders, S | 1 |
Lampas, M | 1 |
Zangari, M | 1 |
Tricot, G | 1 |
Hanson, KE | 1 |
2 other studies available for thalidomide and Cytomegalovirus
Article | Year |
---|---|
Bromodomain proteins regulate human cytomegalovirus latency and reactivation allowing epigenetic therapeutic intervention.
Topics: Azepines; Bacterial Proteins; Benzodiazepines; Cell Cycle Proteins; Cyclin T; Cyclin-Dependent Kinas | 2021 |
Cytomegalovirus reactivation following autologous peripheral blood stem cell transplantation for multiple myeloma in the era of novel chemotherapeutics and tandem transplantation.
Topics: Aged; Antiviral Agents; Boronic Acids; Bortezomib; Cytomegalovirus; Cytomegalovirus Infections; Fema | 2012 |